TOP TIERMARKET NEWSWIRE
News & sentiment

IRIDEX CORP (IRIX) — News & AI sentiment

IRIDEX CORP (IRIX) news roundup. 12 stories aggregated over the last 30 days. Average 30-day sentiment is 47.7/100. Recent insider activity (SEC Form 4, 90-day window): 3 purchases totalling $10K and 0 sales totalling $0 — net buying of $10K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
12
avg sentiment 47.7/100
Insider net (90d)
$10K
3 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

IRIX news in the last 24 hours, 7 days, 30 days and 90 days

How much IRIX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIRIX storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days0no coverage
Last 30 days1247.7/100IRIX headlines →
Last 90 days1949.1/100IRIX headlines →

Latest stories on IRIX

Sep 2
IRIDEX CORP (IRIX) files 8-K
SEC 8-K34 · bearishgeneral
Sep 2
Aug 25
IRIDEX (IRIX) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Aug 25
Aug 20
Aug 19
Aug 19
Aug 19
IRIDEX CORP (IRIX) files 8-K
SEC 8-K50 · neutralgeneral
Aug 18
Aug 18
Aug 18
Iridex Reports Second Quarter 2026 Financial Results
Business Insider50 · neutralearnings
Aug 18
Aug 4
Jul 20
Jul 20
Jul 17
IRIDEX CORP (IRIX) files 8-K
SEC 8-K50 · neutralgeneral
Jul 16
Jun 18
IRIDEX CORP (IRIX) files 8-K
SEC 8-K50 · neutralgeneral
Jun 18
May 20
May 20
May 19
May 19
May 19
Open IRIX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →